TSE:7777Biotechs
3-D Matrix (TSE:7777) Profitability Swing In Q3 2026 Tests Rich P/E Narrative
3-D Matrix (TSE:7777) has just posted its Q3 2026 scorecard, with revenue of ¥2,539 million and net income of ¥653 million, translating to basic EPS of ¥5.39. The company has seen quarterly revenue range from ¥1,875 million in Q4 2025 to ¥2,613 million in Q2 2026, while basic EPS has swung from a loss of ¥10.11 in Q4 2025 to a gain of ¥7.96 in Q2 2026 and ¥5.39 this quarter. This reflects a move from losses to profits over the recent reporting periods. For investors, that combination of...